Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Aktana

Explore full profile

CRM Suggestions For Pharmaceutical Sales Reps | Aktana

San Francisco, United StatesFounded 2011Marketing
Valuation $100–250M Last recorded · 2018
Headcount 100–500 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Aktana and the history behind them.

About Aktana

Aktana is a company that specializes in providing decision support technology for the life sciences industry, particularly in marketing and sales. The company leverages artificial intelligence (AI) to help life science companies make informed decisions by analyzing vast amounts of data. This data includes market trends, channel activities, and healthcare provider (HCP) preferences. By doing so, Aktana enables these companies to deliver the right information to physicians and their patients at the right time.

Aktana primarily serves life science companies, which include pharmaceutical, biotechnology, and medical device firms. These companies operate in a highly regulated and competitive market where timely and accurate information is crucial for success. Aktana's technology helps these companies enhance their commercial engagement strategies, especially in a landscape that has been significantly impacted by events like the COVID-19 pandemic.

The business model of Aktana revolves around providing software solutions that integrate seamlessly with the existing systems of their clients. They offer their technology as a service, which means clients pay for access to the software and its features, often through subscription-based pricing. This model ensures a steady stream of revenue for Aktana while providing continuous value to their clients through regular updates and improvements.

Aktana makes money by selling these AI-driven decision support solutions to life science companies. Their clients benefit from improved efficiency and effectiveness in their marketing and sales efforts, which can lead to better patient outcomes and increased revenues. Aktana's technology is designed to scale easily, making it suitable for both small and large life science companies.

In summary, Aktana is a key player in the life sciences market, providing AI-enabled decision support technology that helps companies make data-driven decisions. Their solutions are crucial for enhancing commercial engagement and ensuring that the right information reaches the right people at the right time.

Source: Dealroom company data

At a glance

Status
Acquired
Founded
2011
Headquarters
San Francisco, United States
Employees
122
Open positions
None listed
Dealroom signal
62.1/100
Industry
Marketing
Sub-industry
CRM & Sales
Sector
Marketing, Analytics, CRM, Core AI, Pharmaceutical, Life Science, AI Applications
Technology
Artificial Intelligence, Machine Learning
Client focus
b2b

Funding history

10 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Jan 2026 $0 — PharmaForceIQ ↗
DEBTDebt Jan 2021 $30M — Armentum Partners —
Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Growth signals

Aktana website traffic

Latest recorded traffic for Aktana is 2.7K monthly website visits, down 6.9% over the last three months. Aktana's team declined 29.5% over the past year.

Latest monthly visits2.7K 3-month web change-6.9% 1-year team growth-29.5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Starfish Ventures

Series B and later3 investors entered at this stage

  • Transformation Capital
  • CIBC Innovation Banking
  • Armentum Partners

Other known investors6 additional known investors

Team profiled 32 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 6 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
9 countries with
team presence
🇺🇸 United States34%
🇨🇳 China27.7%
🇮🇳 India12.8%
🇯🇵 Japan8.5%
🇪🇸 Spain4.3%
Top 5 of 9 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Aktana on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Aktana’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.